Thompson Davis & Co’s Insmed INSM Stock Holding History

Thompson Davis & Co’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$10K	Hold	500	–	–	0.02%	447
2018 Q2	$12K	Hold	500	–	–	0.03%	404
2018 Q1	$11K	Hold	500	–	–	0.03%	384
2017 Q4	$16K	Hold	500	–	–	0.04%	346
2017 Q3	$16K	Hold	500	–	–	0.03%	545
2017 Q2	$9K	Hold	500	–	–	0.01%	685
2017 Q1	$9K	Hold	500	–	–	0.01%	716
2016 Q4	$7K	Hold	500	–	–	0.01%	783
2016 Q3	$7K	Hold	500	–	–	0.01%	751
2016 Q2	$5K	Hold	500	–	–	0.01%	784
2016 Q1	$6K	Hold	500	–	–	0.01%	747
2015 Q4	$9K	Hold	500	–	–	0.01%	682
2015 Q3	$9K	Hold	500	–	–	0.01%	683
2015 Q2	$12K	Hold	500	–	–	0.01%	676
2015 Q1	$10K	Hold	500	–	–	0.01%	727
2014 Q4	$8K	Hold	500	–	–	0.01%	814
2014 Q3	$7K	Hold	500	–	–	0.01%	794
2014 Q2	$10K	Sell	500 -500	-50%	-$7.4K	0.01%	484
2014 Q1	$19K	Hold	1,000	–	–	0.03%	391
2013 Q4	$17K	Buy	+1,000	New	+$15.3K	0.03%	370

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

Thompson Davis & Co's INSM Position: Q3 2018 in Review

Thompson Davis & Co held its Insmed (INSM) position steady in Q3 2018 at 500 shares worth $10K. The position accounts for 0.02% of the portfolio, ranked #447.

Thompson Davis & Co first reported a position in INSM in Q4 2013 and has held it in 20 quarters since. The position peaked at $19K in Q1 2014. 123 funds tracked by Wall St. Rank hold INSM as of Q3 2018.

Thompson Davis & Co held 500 shares of Insmed worth $10K as of Q3 2018.
Thompson Davis & Co left its Insmed share count unchanged in Q3 2018.
Insmed made up 0.02% of Thompson Davis & Co's portfolio in Q3 2018, its #447 holding.
Thompson Davis & Co first reported a position in Insmed in Q4 2013 and has held it in 20 quarters since.
Thompson Davis & Co's Insmed position peaked at $19K in Q1 2014.
123 funds tracked by Wall St. Rank held Insmed as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.